Back to top
more

SEQUENOM INC (SQNM)

(Delayed Data from NSDQ)

$2.39 USD

2.39
2,043,237

-0.01 (-0.42%)

Updated Sep 6, 2016 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Better trading starts here.

Brokerage Reports

0 items in cart

[SQNM]

Reports for Purchase

Showing records 1 - 20 ( 188 total )

Industry: Medical - Biomedical and Genetics

Record: 1

11/22/2015

Company Report

Pages: 10

Model Update - Tweaking Revenue - GMs Forecasts - Remaining Cautious Post NTRA Results - Maintain N

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 2

10/27/2015

Company Report

Pages: 8

Expecting Weak 3Q15 Results Post Preannouncement - Pricing - Share Loss in Focus - Bold Restructuring Is In Order - Maintain NEUTRAL

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 3

09/28/2015

Company Report

Pages: 9

Lowering Estimates - PT Following Weak Guidance Update - Competition - Pricing At Issue - Reducing PT to $1.50

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 4

08/06/2015

Company Report

Pages: 9

2Q15 Recap - Revenue Soft - Volume Growth In-line - ILMN Patent Pool Less Lucrative Than We Were Thinking - Lowering PT to $2.50 - Maintain N

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 5

08/03/2015

Company Report

Pages: 8

2Q15 Preview - Consensus Revenue Forecasts Appear Overly Negative - Market Share - ASPs Appear Ok - Maintain NEUTRAL - Lowering PT to $3.50

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 6

06/29/2015

Daily Note

Pages: 7

ACOG Updates NIPT Guidelines - Slight Positive, In Our View, But Kneejerk Investor Reaction May Be Negative - Maintain N

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 7

06/29/2015

Daily Note

Pages: 7

ACOG Updates NIPT Guidelines - Slight Positive, In Our View, But Kneejerk Investor Reaction May Be Negative - Maintain N

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 8

05/07/2015

Company Report

Pages: 10

Downgrading to NEUTRAL from OUTPERFORM Following So So 1Q15 Results - Moving to Sidelines After Recent Runup - Just Ok Volume - Sales Growth

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 9

03/05/2015

Company Report

Pages: 10

Wobbly 4Q Sales Offset by GM Strength - Breakeven - Market Share Story Intact - Karyotype Test - Avg. Risk Catalyst Are Reasons to Own - Maintain OP

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 10

02/27/2015

Industry Report

Pages: 6

The Week Ahead in Life Sciences - Upcoming Events from the Week of March 2

Provider: WEDBUSH SECURITIES INC.

Analyst: MOUSSATOS L

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 11

02/25/2015

Company Report

Pages: 9

4Q14 Preview - Expecting In-Line Results

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 12

11/05/2014

Company Report

Pages: 10

3Q14 Test Volumes & Sales Soft Due to Competition & Seasonality - October Results Peek Provides Confidence - Opex Very Good - PT to $4.50 - Maintain OP

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 13

10/30/2014

Company Report

Pages: 9

Risk Reward Favorable Going in to 3Q Earnings - Checks Suggest Stable Reimbursement - Minor Quest, VisibiliT & Mayo Sales Built In - Maintain OP

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 14

09/16/2014

Industry Report

Pages: 4

Medical Diagnostics and Life Sciences Tools - Ariosa Publishes New NIPT Approach

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 15

08/13/2014

Industry Report

Pages: 15

LIFE SCIENCES AND HEALTH CARE-2014 LSMAC Day 1

Provider: WEDBUSH SECURITIES INC.

Analyst: MOUSSATOS L

Price: 50.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 16

08/13/2014

Daily Note

Pages: 15

2014 LSMAC Day 1

Provider: WEDBUSH SECURITIES INC.

Analyst: MOUSSATOS L

Price: 50.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 17

07/30/2014

Company Report

Pages: 11

Pro-Forma 2Q14 Results Solid - Volumes Good Enough - GM & Opex Improve- Announces Mayo Clinic Deal

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 18

07/27/2014

Industry Report

Pages: 6

LIFE SCIENCES AND HEALTH CARE

Provider: WEDBUSH SECURITIES INC.

Analyst: MOUSSATOS L

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 19

07/21/2014

Company Report

Pages: 8

Expecting in-line 2Q14-Updating Model to Reflect Pro Forma 2Q14

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 20

06/27/2014

Industry Report

Pages: 6

LIFE SCIENCES AND HEALTH CARE - The Week Ahead in Life Sciences - Upcoming Events for the Week of June 30

Provider: WEDBUSH SECURITIES INC.

Analyst: MOUSSATOS L

Price: 25.00

Research Provided by a Third Party

// eof